Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jain PharmaBiotech is a specialized biotechnology and pharmaceutical consultancy based in Basel, Switzerland, founded by the late Dr. Kewal K. Jain. The firm is primarily known for its high-level strategic consulting and the publication of comprehensive market research reports that analyze emerging technologies in the life sciences. Its expertise covers a wide range of advanced fields, including personalized medicine, gene therapy, cell therapy, molecular diagnostics, and nanobiotechnology. Although the company does not develop its own therapeutic pipeline, its technical reports and textbooks are widely cited by industry professionals and academic researchers for their depth and foresight into the biopharmaceutical landscape. The company's work has significantly contributed to the industry's understanding of how nanotechnology and genomics are transforming modern medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jain PharmaBiotech.